Citigroup Inc Cytokinetics Inc Call Options Transaction History

Citigroup Inc

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 12, 2024	BUY	$51.22 - $60.16 $4.39 Million - $5.16 Million	85,700 Added 71.6%	205,400 $10.8 Million
Q2 2024 Aug 12, 2024	BUY	$47.86 - $75.05 $5.73 Million - $8.98 Million	119,700 New	119,700 $6.49 Million
Q4 2023 Feb 09, 2024	BUY	$26.88 - $83.49 $4.86 Million - $15.1 Million	180,900 New	180,900 $15.1 Million
Q2 2023 Aug 10, 2023	SELL	$32.62 - $40.75 $959,027 - $1.2 Million	-29,400 Reduced 34.83%	55,000 $1.79 Million
Q1 2023 May 11, 2023	BUY	$33.36 - $45.71 $1.81 Million - $2.49 Million	54,400 Added 181.33%	84,400 $2.97 Million
Q4 2022 Feb 09, 2023	BUY	$35.77 - $51.11 $1.07 Million - $1.53 Million	30,000 New	30,000 $1.37 Million
Q2 2022 Aug 10, 2022	BUY	$33.93 - $48.92 $678,600 - $978,400	20,000 New	20,000 $786,000

409

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.57B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.